Immunomodulatory strategies for relapse after haploidentical hematopoietic stem cell transplantation in hematologic malignancy patients.
about
HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplanta
P2860
Immunomodulatory strategies for relapse after haploidentical hematopoietic stem cell transplantation in hematologic malignancy patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunomodulatory strategies fo ...... matologic malignancy patients.
@en
Immunomodulatory strategies fo ...... matologic malignancy patients.
@nl
type
label
Immunomodulatory strategies fo ...... matologic malignancy patients.
@en
Immunomodulatory strategies fo ...... matologic malignancy patients.
@nl
prefLabel
Immunomodulatory strategies fo ...... matologic malignancy patients.
@en
Immunomodulatory strategies fo ...... matologic malignancy patients.
@nl
P1476
Immunomodulatory strategies fo ...... ematologic malignancy patients
@en
P2093
Xiao-Jun Huang
P304
P356
10.1016/J.BEHA.2011.04.002
P577
2011-06-25T00:00:00Z